Sequential first-pass elimination of a metabolite derived from a precursor
- 1 June 1979
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 7 (3), 275-290
- https://doi.org/10.1007/bf01060018
Abstract
We examined data from our previous studies in which we not only delivered perfusate containing tracer concentrations of [14C]phenacetin and its metabolite [3H]acetaminophen under constant perfusate flow (10 ml/ min/ liver) into the rat liver preparation just once, but also recirculated fresh reservoir perfusate containing a tracer dose of [14C]phenacetin through the same rat liver preparation. From the single-pass studies, estimates of fm, the fractional rate of conversion for [14C]phenacetin to form [14C]acetaminophen, and F(M.P), the apparent availability of [14C]acetaminophen, were obtained by determining the concentrations of [14C]acetaminophen in the perfusate before and after incubation with Glusulase. These estimates were fm=0.871±0.16 and F(M.P)=0.43±0.10. These and the steady-state clearance values of phenacetin (9.1±0.8ml/min) and acetaminophen (6.7±0.7ml/min) from the single-pass studies were used to predict the concentrations of [14C]acetaminophen in the reservoir perfusate on recirculation of [14C]phenacetin. We found that the sequential first-pass elimination of the metabolite must be considered when the metabolite is highly extracted by the liver. If we had neglected to take this into account, the fractional rate of conversion of a precursor to form a metabolite and the rate of formation of the metabolite would have been underestimated by the factor F(M.P).This publication has 12 references indexed in Scilit:
- Theoretical Relationships between Area under the Curve and Route of Administration of Drugs and Their Precursors for Evaluating Sites and Pathways of MetabolismJournal of Pharmaceutical Sciences, 1978
- Hepatic clearance of drugs. III. Additional experimental evidence supporting the “wellstirred” model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liverin situ preparationJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Pharmacokinetics of isoniazid and some metabolites in manJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Utilization of area under the curve to elucidate the disposition of an extensively biotransformed drugJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Renal Contribution to Overall Metabolism of Drugs II: Biotransformation of Salicylic Acid to Salicyluric AcidJournal of Pharmaceutical Sciences, 1972
- Pharmacokinetic Model for Chlordiazepoxide·HCl in the DogJournal of Pharmaceutical Sciences, 1970
- Pharmacokinetics of Acetylsalicylic Acid and Salicylic Acid After Intravenous Administration in ManJournal of Pharmaceutical Sciences, 1968
- Pharmacokinetics of Salicylate Elimination in ManJournal of Pharmaceutical Sciences, 1965